Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Marathon Oil: Buy on the Second Dip?

I couldn’t tell you what’s going to happen in either quarter, but what I do know is that Marathon’s current FCF yield is 8.6% if you base it on a market capitalization of $4.4 billion, and 4.2% based on an enterprise value of $9.1 billion.

Dump United Airlines and Buy Apple Instead

As for United Airlines stock, I continue to advocate that if you must invest in the airlines, do so through the U.S. Global Jets ETF (NYSEARCA:JETS), which has seen assets under management skyrocket in 2020 due to Covid-19.

7 Hot Stocks to Stay Hot for Years to Come

In mid-June, I argued that DraftKings stock was worth betting on, regardless of what happens to sports in the near term. Simply put, the long-term potential for sports betting on a global basis is enormous.

If You Bought Gap Stock Below $10, It’s Time to Take Profits

Gap stock has made some quick money for contrarians who went bottom-fishing this year. But if that's you, it's now time to take profits.

Taxpayers Ought to Avoid American Airlines Stock

It’s okay for taxpayers to bail out the airlines. Yet, for some reason, the passengers (the same taxpayers) aren’t allowed to receive a minimum amount of safety while traveling. How ridiculous is that?

Vroom’s Insiders Make It a Long-Term Buy

While Vroom stock has catapulted since its IPO, there's still room for growth because of the big backers supporting the cause.

Here are 2 Great Companies to Invest in on Crowdfunder

One of the top equity crowdfunding portals is Crowdfunder. Here are two companies to invest in from its current fundraising campaigns.

Does Walgreens Stock Need a Positive Earnings Surprise to Move Higher?

Walgreens stock has been uninspiring heading into earnings season. You shouldn't expect too much from WBA.

Did Warren Buffett Contribute to Occidental Pete’s Demise?

For those unfamiliar with Buffett’s relationship with Occidental, his company lent OXY $10 billion last August to help it acquire Anadarko, beating out Chevron (NYSE:CVX) in the process. In hindsight, Chevron’s CEO has got to be ecstatic it lost the fight.

Inovio Pharmaceuticals Comes Up Short in Phase 1

The competition for a Covid-19 vaccine is intense. Inovio needs to provide investors with more information to give INO stock a chance at long-term upside.